These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Regulation of the synthesis and release of slow-reacting substance of anaphylaxis from sensitized monkey lung. Weichman BM; Hostelley LS; Bostick SP; Muccitelli RM; Krell RD; Gleason JG J Pharmacol Exp Ther; 1982 May; 221(2):295-302. PubMed ID: 6176708 [TBL] [Abstract][Full Text] [Related]
43. Interrelationships of SRS-A production and arachidonic acid metabolism in human lung tissue. Walker JL Adv Prostaglandin Thromboxane Res; 1980; 6():115-9. PubMed ID: 6155760 [No Abstract] [Full Text] [Related]
44. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells. Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206 [TBL] [Abstract][Full Text] [Related]
45. Differences in arachidonate metabolism between guinea-pig, rat and human isolated lung [proceedings]. Al-Ubaidi F; Bakhle YS J Physiol; 1979 Jun; 291():41P-42P. PubMed ID: 383953 [No Abstract] [Full Text] [Related]
46. Influence of a beta-adrenergic agonist on septic shock-induced alterations of phosphatidylcholine metabolism in rat lung. von Wichert P; Müller B; Meyer-Ingold W Lung; 1988; 166(5):257-67. PubMed ID: 3146672 [TBL] [Abstract][Full Text] [Related]
47. Enzymatic inactivation of SRS-Cys-Gly (leukotriene D). Sok DE; Pai JK; Atrache V; Kang YC; Sih CJ Biochem Biophys Res Commun; 1981 Jul; 101(1):222-9. PubMed ID: 6895177 [No Abstract] [Full Text] [Related]
48. Effect of benoxaprofen on release of slow-reacting substances from human lung tissue in vitro. Lee VY; Hughes JM; Seale JP; Temple DM Clin Sci (Lond); 1982 Aug; 63(2):219-21. PubMed ID: 7083781 [TBL] [Abstract][Full Text] [Related]
49. Interaction between the release of SRS-A and of prostaglandins [proceedings]. Engineer DM; Piper PJ; Sirois P Br J Pharmacol; 1976 Jul; 57(3):460P-461P. PubMed ID: 974351 [No Abstract] [Full Text] [Related]
50. Leukotrienes: a novel group of compounds including SRS-A. Samuelsson B Prog Lipid Res; 1981; 20():23-30. PubMed ID: 7342087 [No Abstract] [Full Text] [Related]
53. Prostaglandin D2 in the skin. Ikai K; Imamura S Int J Dermatol; 1988 Apr; 27(3):141-9. PubMed ID: 3286543 [No Abstract] [Full Text] [Related]
54. Leukotriene release in chopped human lung: characteristics and regulation. Kumlin M; Dahlén SE Agents Actions; 1989 Jan; 26(1-2):84-6. PubMed ID: 2540648 [No Abstract] [Full Text] [Related]
55. Release of leukotrienes, induced by the Ca++ ionophore A23187, from human lung parenchyma in vitro. Sautebin L; Viganò T; Grassi E; Crivellari MT; Galli G; Berti F; Mezzetti M; Folco G J Pharmacol Exp Ther; 1985 Jul; 234(1):217-21. PubMed ID: 2989505 [TBL] [Abstract][Full Text] [Related]
56. Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists. Hughes JM; Seale JP; Temple DM Eur J Pharmacol; 1983 Nov; 95(3-4):239-45. PubMed ID: 6197312 [TBL] [Abstract][Full Text] [Related]
57. Stimulus-related difference in the formation of leukotrienes and PGD2 after immunological and non-immunological challenge of human lung parenchyma "in vitro". Viganò T; Sautebin L; Magni F; Crivellari MT; Paganelli R; Galli G; Berti F; Folco G Prostaglandins Leukot Med; 1986 Aug; 23(2-3):109-15. PubMed ID: 3020580 [TBL] [Abstract][Full Text] [Related]
58. Arachidonic acid metabolites in the healthy and diseased lung. Newman JH; Sheller JR Am J Med Sci; 1984 Sep; 288(2):75-80. PubMed ID: 6091454 [No Abstract] [Full Text] [Related]
59. Effect of the beta-2 adrenergic agonist fenoterol on the release of leukotrienes and prostaglandin D2 from human lung parenchyma. Viganò T; Sautebin L; Crivellari MT; Galli G; Mezzetti M; Folco GC Wien Klin Wochenschr; 1986 Feb; 98(4):120-22. PubMed ID: 3085356 [TBL] [Abstract][Full Text] [Related]